An oft-repeated message is that primary aldosteronism is not rare; it is quite common. An equally urgent message is that ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Dr. Marwan G. Fakih discussed the FDA approval of Lumakras with Vectibix for third-line treatment of KRAS G12C-mutated ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment ... Sign up here to get The Results ...

Estimates for payrolled employees in the UK decreased by 32,000 (0.1%) between October and November 2024 but rose by 95,000 (0.3%) between November 2023 and November 2024. Payrolled employees fell by ...

Amgen’s LUMAKRAS (sotorasib) and Vectibix (panitumumab ... the Phase III CodeBreaK 300 trial which showed the therapy combination as the first targeted treatment duo for chemorefractory KRAS ...

The Food and Drug Administration has approved Amgen sotorasib (Lumakras) with panitumumab (Vectibix) for adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC), as determined by an ...

"On their path to get treatment, they are forced to sleep on roads, footpaths and subways - just keeping a flame of hope burning amidst the cold ground, hunger, and inconveniences," Gandhi said.

"Colorectal cancer is the third leading cause of cancer-related deaths in the United States, and fewer than one in five people diagnosed with metastatic disease survive beyond five years after ...

Future data on overall survival will be beneficial for prescribing the treatment to patients after the approval. 1. FDA approves sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer.

Treatment for sleep apnea aims to improve your breathing during sleep and reduce the risk of underlying health concerns. Common options include CPAP machines, oral devices, and lifestyle measures ...